Hepatitis D virus infection in persons with HIV and hepatitis B virus across Europe: A cross‐sectional analysis of the HDV‐Europe cohort

Anders Boyd, Thomas Lutz, Kathrin van Bremen, Alessandro Tavelli, Antonella d'Arminio Monforte, Marc van der Valk, Miłosz Parczewski, Magdalena Tchorz, Iwona Cielniak, Luz Martín‐Carbonero, María del Mar Arcos‐Rueda, Charles Béguelin, Gilles Wandeler, Sanjay Bhagani, Charlotte Lim, Fauzi Elamouri, Juan Berenguer, Jürgen K. Rockstroh, Pablo Ryan
HIV Medicine · Wiley · 2026-10-15 · DOI: 10.1111/hiv.70320

Аннотация

Abstract Introduction Infection with hepatitis D virus (HDV) is known to accelerate the progression of liver disease and is associated with mortality in individuals with HIV and hepatitis B virus (HBV). However, little is known about current HDV epidemiology, including HDV‐testing practices and prevalence, in this population in Europe. Methods We conducted a cross‐sectional study of clinical cohorts across Europe (Germany, Italy, the Netherlands, Poland, Spain, Switzerland and United Kingdom). Included individuals were those living with HIV, ever hepatitis B surface antigen positive, aged ≥18 years and actively in care on December 31, 2023. We calculated the percentage of individuals tested for HDV, prevalence of individuals who ever had anti‐HDV positive serology (i.e., past/current infection) and the prevalence of individuals whose last HDV RNA result was positive (i.e., active infection). Results A total of 2970 individuals were included. Anti‐HDV antibody results were available in 2189 (73.7%). Of them, 261 (12.0%) had past/current HDV infection, ranging between 3.8% in the United Kingdom and 27.3% in Poland. Among the 261 individuals with an anti‐HDV‐positive result, 162 (62.1%) had been tested for HDV RNA. Of them, 92 (56.8%) had active HDV infection. Of the overall population with available data, active HDV infection was observed in 4.4% ( n = 92/2077), ranging between 0.9% in the Netherlands and 11.0% in Italy. Conclusions In Europe, about one‐eighth of individuals with HIV/HBV in care have evidence of past/current HDV infection, in whom half have active HDV infection. Nevertheless, these results come from a setting where one‐quarter have yet to be tested for anti‐HDV antibodies.

Читать у издателя →

Похожие статьи